Press release
Breakthroughs in Blood Disorder Therapies Propel Antithrombin Market Toward Robust Global Growth 2025 | Top key players - CSL Limited, Grifols SA, Takeda Pharmaceuticals
Antithrombin Market
The Antithrombin Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product portfolios, pricing models, financial performance, growth initiatives, and regional presence.
Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/antithrombin-market?sz
The Antithrombin market refers to the global industry focused on the production, development, and distribution of antithrombin products proteins that inhibit blood clotting by neutralizing enzymes like thrombin. These products are used in treating hereditary antithrombin deficiency, preventing thrombosis, and managing coagulation during surgeries. Market growth is driven by rising awareness, advancements in biologics, and increasing surgical procedures.
Major players in the Antithrombin Market
The prominent players in Antithrombin market research report are: CSL Limited, Grifols SA, Takeda Pharmaceuticals, Octapharma AG, LFB USA, Axis-Shield Plc, Siemens AG, Thermo Fisher Scientific, Lee Biosolutions Inc., BDI Pharma, among others.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
In July 2022, Fitusiran, a prophylactic treatment for hemophilia A and B, demonstrated a significant reduction in bleeding episodes compared to previous therapies using factor or bypassing agents, regardless of the presence of inhibitors. Clinical results showed a 61% decrease in bleeding events, underscoring Fitusiran's potential as a more effective treatment option for individuals with hemophilia.
In February 2022, Novo Holdings A/S, a prominent life sciences investor, announced its participation in Hemab Therapeutics' Series B financing round, which raised $135 million. Hemab Therapeutics is a clinical-stage biotech company focused on developing innovative preventive therapies for bleeding and thrombotic disorders that currently lack effective treatment options. The investment supports the company's mission to address critical unmet needs in patients with severe and underserved hematological conditions.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/antithrombin-market
Market Segments
By Usage: Therapeutics, Diagnostics, Research, Other.
By Type: Anticoagulant, Antiplatelet, Thrombolytic Drug.
By Route of Administration: Oral, Parenteral.
By Source: Human, Recombinant Goat milk, Others.
The Antithrombin industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Antithrombin Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breakthroughs in Blood Disorder Therapies Propel Antithrombin Market Toward Robust Global Growth 2025 | Top key players - CSL Limited, Grifols SA, Takeda Pharmaceuticals here
News-ID: 4061328 • Views: …
More Releases from DataM Intelligence 4Market Research
Benzodiazepine Drugs Market Trends, Growth Forecast, and Top Companies 2025 | Pf …
The Global Benzodiazepine Drugs Market is estimated to reach at a CAGR of 2.29% during the forecast period 2024-2031.
The Benzodiazepine Drugs Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product portfolios, pricing models, financial performance, growth initiatives, and regional presence.
Unlock exclusive insights…
Breakthrough Therapies and Rising Cases Fuel Growth in Global Thyroid Cancer Tre …
The Global Thyroid Cancer Treatment Market size reached US$ 1.14 billion in 2024 and is expected to reach US$ 2.94 billion by 2033, growing at a CAGR of 11.2% during the forecast period 2025-2033.
The Thyroid Cancer Treatment Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players…
Global Pet Food Market Surges as Pet Humanization Drives Demand for Premium and …
The Global Pet Food Market reached USD 120.3 billion in 2022 and is expected to reach USD 179.0 billion by 2031 growing with a CAGR of 5.1% during the forecast period 2024-2031.
The Pet Food Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their…
Global Food Probiotics Market Surges as Demand for Gut Health and Functional Foo …
The Global Food Probiotics Market reached USD 60.5 billion in 2022 and is expected to reach USD 100.1 billion by 2031 and is expected to grow with a CAGR of 6.5% during the forecast period 2024-2031.
The Food Probiotics Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major…
More Releases for Antithrombin
Antithrombin Market Report Up to 2031
Visiongain has published a new report on Antithrombin Market Report to 2031. Market is segmented by source (Human, Goat milk, others), By Application (Therapeutics, Research, Diagnostic, Others), By Type (Anticoagulants, Antiplatele, Thrombolytic Drugs). Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Antithrombin Companies. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/antithrombin-market/#download_sampe_div
The study covers detailed and insightful chapters…
Global Antithrombin Market Data Survey Report 2025
The Global Antithrombin Market advertises highlights a combined merchant scene with the nearness of a bunch of set up players that are scattered in local and Global markets. The Global Antithrombin Market is likewise portrayed by hardened rivalry with the predominance of a couple of players that involve driving income base. With the passage of new players in this market, which has sufficient development prospects, the opposition is probably going…
Antithrombin Market Analysis 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI…
Antithrombin Market - Size, Share, Outlook, 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI…
Antithrombin Market analysis 2026
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin. Antithrombin is produced by liver and consists of 432 amino acids. There are two major reasons of antithrombin deficiency, which include acquired antithrombin deficiency caused due to other diseases such as nephrotic syndrome, liver failure, severe trauma, and metastatic tumors and inherited antithrombin deficiency caused due to a genetic mutation or abnormality. According to the NCBI…
Antithrombin (recombinant) Market Research Report Forecast to 2024
Antithrombotic drugs help in the prevention or inhibition of thrombus by mimicking the role of antithrombin, a protein molecule produced in our body which helps in clotting. The protein molecule is produced by the liver, and among other benefits, has anti-inflammatory effects. Engineered recombinant antithrombin has gained clinical significant in recent years for the prevention of various peri-partum and peri-operative thromboembolic events or blood clots.
A notable development in the market…
